The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Comparative efficacy of Bruton tyrosine kinase inhibitors in the treatment of relapsed/refractory chronic lymphocytic leukemia: A network meta-analysis (NMA).
 
Mazyar Shadman
Employment - Bristol-Myers Squibb (I)
Consulting or Advisory Role - Abbvie; AstraZeneca; BeiGene; Bristol-Myers Squibb/Celgene; Fate therapeutics; Genentech; Genmab; Kite, a Gilead company; Lilly; Merck; MorphoSys; Nurix; Pharmacyclics; Regeneron
Research Funding - Abbvie (Inst); Acerta Pharma (Inst); BeiGene (Inst); Bristol-Myers Squibb/Celgene; Celgene (Inst); Genentech (Inst); Genmab (Inst); Merck (Inst); MustangBio (Inst); Pharmacyclics (Inst); Sunesis Pharmaceuticals (Inst); TG Therapeutics (Inst); Vincerx Pharma (Inst)
 
Jennifer R. Brown
Consulting or Advisory Role - Abbvie; Acerta/Astra-Zeneca; Alloplex Biotherapeutics Inc; BeiGene; Genentech/Roche; Grifols Worldwide Operations; HUTCHMED; iOnctura; Kite, a Gilead company; Loxo/Lilly; Merck; Numab; Pfizer; Pharmacyclics
Research Funding - BeiGene (Inst); Gilead Sciences (Inst); iOnctura; Loxo/Lilly (Inst); MEI Pharma (Inst); Secura Bio (Inst); TG Therapeutics (Inst)
 
Leyla Mohseninejad
Employment - BeiGene; Evidera/PPD
Stock and Other Ownership Interests - BeiGene
 
Keri Yang
Employment - BeiGene
Stock and Other Ownership Interests - BeiGene
 
Heather Burnett
Employment - AstraZeneca (I)
Stock and Other Ownership Interests - AstraZeneca (I)
 
Binod Neupane
No Relationships to Disclose
 
Rhys Williams
Employment - BeiGene
 
Nicole Lamanna
Consulting or Advisory Role - Abbvie; Allogene Therapeutics; AstraZeneca; BeiGene; Bristol Myers Squibb Foundation; Celgene; Genentech; Gilead Sciences; Janssen; Juno Therapeutics; Loxo/Lilly; pharmacyclics; ProNAi; Roche
Research Funding - Abbvie (Inst); Acerta Pharma/AstraZeneca (Inst); AstraZeneca (Inst); Beigene (Inst); Genentech/Abbvie (Inst); Genmab (Inst); Gilead Sciences (Inst); Infinity Pharmaceuticals (Inst); Juno Therapeutics (Inst); Loxo (Inst); MingSight (Inst); Octapharm (Inst); Oncternal Therapeutics, Inc (Inst); ProNAi (Inst); TG Therapeutics (Inst); Verastem (Inst)
 
Susan M. O'Brien
Consulting or Advisory Role - Abbvie; Alexion Pharmaceuticals; Amgen; Aptose Biosciences; Astellas Pharma; AstraZeneca; Autolus; Bristol Myers Squibb Foundation; Gilead Sciences; GlaxoSmithKline; Janssen Oncology; JJ Innovative Medicine; Lilly; MEI Pharma; Merck; Pharmacyclics; Secura Bio; TG Therapeutics; Vaniam Group
Research Funding - Acerta Pharma; Alliance Pharma; BeiGene; Caribou Biosciences; Gilead Sciences; Loxo; MustangBio; Nurix; Pharmacyclics; Regeneron; Secura Bio; TG Therapeutics
 
Alessandra Tedeschi
Consulting or Advisory Role - Abbvie; AstraZeneca; Beigene; Janssen
Speakers' Bureau - Abbvie; AstraZeneca; Beigene; Janssen
 
Constantine S. Tam
Honoraria - Abbvie; Beigene; Janssen-Cilag; Loxo/Lilly; Novartis; Pharmacyclics; Roche/Genentech
Consulting or Advisory Role - Abbvie; BeiGene; Janssen; Loxo; Roche
Research Funding - Abbvie (Inst); BeiGene (Inst); Janssen-Cilag (Inst)